"p"Founded in Sydney, in 1932 by Jacob Bloch, Bloch is a pioneer in the technical dance market. Since its inception, the renowned footwear brand has produced handmade pointe shoes for esteemed ballet dancers worldwide. Bloch recently entered an exciting new period of innovation and fashion design with the creation of mainstream footwear, following the demands by current customers to create street-ready shoes.
"h2"From the manufacturer
It all started with a promiseâ¦
...to make the most comfortable dance shoes in the world.
Jacob Bloch, a shoe maker by trade, emigrated to Australia in 1930 during the height of The Great Depression.
Jacob's love of music and dancing took him to the local ballet schools and at one of these schools he noticed a young dancer struggling to stay en pointe. Jacob promised he would make her a better pair of pointe shoes to dance in, and so he did.
Jacobâs reputation for making high-quality dance footwear spread rapidly.
Jacobâs shoes became so well-known and sought after, that it sparked the creation of a full range of dance footwear and dance fashion products. The brand grew rapidly and over time became the BLOCH we know and love.
Today, BLOCH has a reputation as one of the most trusted in the industry and is still fulfilling the promise made by its founder close to nine decades ago; "to make the most comfortable dance shoe in the world".
Cancer is relentless. But so are we. Whether you fundraise, volunteer, pledge to leave a Gift in your Will or donate, everyone has a part to play. And every part supports life-saving research. Play your part and together we will beat cancer.
It’s a worrying time for many people and we want to be there for you whenever - and wherever - you need us. Cancer Chat is our fully moderated forum where you can talk to others affected by cancer, share experiences, and get support. Cancer Chat is free to join and available 24 hours a day.
*Ahmad AS et al, British Journal of Cancer, 2015. **No purchase necessary. Terms and Conditions apply. UK and 18+ only. Closes 30/01/2022.
Minimum guaranteed £100,000 to Cancer Research UK. Promoter: Omaze Limited.